The Valley Desk

ArticleClinical lymphoma, myeloma & leukemiaPublished

Relative Effectiveness of Talquetamab Versus Real-World Physician's Choice Treatment Regimens in Patients With Relapsed/Refractory Multiple Myeloma: Updated Results From an Indirect Treatment Comparison

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Clinical lymphoma, myeloma & leukemia
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Antibodies, Bispecific; Treatment Outcome; Aged; Middle Aged; Female; Male; Bispecific antibody; Real-world Data; Flatiron Health
PubMed ID
41565510
Added to directory
Source checked

Report a correction or request removal